Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.
about
Mitochondrial Regulation of the Muscle Microenvironment in Critical Limb IschemiaThe potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophyExtending the translational potential of targeting NO/cGMP-regulated pathways in the CVSThe new horizons of pharmacotherapy. Unexpected pharmacological actions and a new therapeutic strategy of phosphodiesterase-5 inhibitorsDystrophic Cardiomyopathy-Potential Role of Calcium in Pathogenesis, Treatment and Novel TherapiesSildenafil increases muscle protein synthesis and reduces muscle fatigue.PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy.Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy.One year outcome of boys with Duchenne muscular dystrophy using the Bayley-III scales of infant and toddler development.Loss of nNOS inhibits compensatory muscle hypertrophy and exacerbates inflammation and eccentric contraction-induced damage in mdx mice.Challenges in understanding psychiatric disorders and developing therapeutics: a role for zebrafish.Angiotensin-dependent autonomic dysregulation precedes dilated cardiomyopathy in a mouse model of muscular dystrophy.Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.Nonmechanical Roles of Dystrophin and Associated Proteins in Exercise, Neuromuscular Junctions, and Brains.Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.2015 William Allan Award.Hypoxia-induced cardiac injury in dystrophic mice.Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin-Deficient Hearts.Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A.Therapeutic advances in muscular dystrophyAutonomic dysfunction in muscular dystrophy: a theoretical framework for muscle reflex involvement.Hyperactive adverse mechanical stress responses in dystrophic heart are coupled to transient receptor potential canonical 6 and blocked by cGMP-protein kinase G modulation.Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy.Functional muscle ischemia in Duchenne and Becker muscular dystrophy.Nitric oxide synthase deficiency and the pathophysiology of muscular dystrophy.Nitric Oxide Regulates Skeletal Muscle Fatigue, Fiber Type, Microtubule Organization, and Mitochondrial ATP Synthesis Efficiency Through cGMP-Dependent Mechanisms.Building dialogues between clinical and biomedical research through cross-species collaborations.Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy.Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophyPathways Implicated in Tadalafil Amelioration of Duchenne Muscular Dystrophy.A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension.HANAC Col4a1 Mutation in Mice Leads to Skeletal Muscle Alterations due to a Primary Vascular Defect.Fast skeletal myofibers of mdx mouse, model of Duchenne muscular dystrophy, express connexin hemichannels that lead to apoptosis.Sodium nitrate alleviates functional muscle ischaemia in patients with Becker muscular dystrophy.A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy.Effects of Sildenafil on Cerebrovascular Reactivity in Patients with Becker Muscular Dystrophy.Zebrafish as a Model for the Study of Solid Malignancies.Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.Altered somatosensory neurovascular response in patients with Becker muscular dystrophy.
P2860
Q26774784-AA1A24E4-3275-41C5-8F6A-CF233FE14B21Q26827638-9436C786-996A-4794-ACB7-51A1DA2BFA97Q27021649-7D034D8E-402C-4BE6-8B15-393F932EAB98Q27025700-99CFE5C3-E6BC-438D-ADF1-23A243AF5251Q33608478-92103726-1FFE-4768-B673-C0DEAD94D8A6Q33827719-E199F7F7-AA82-4C55-957B-5F4546A54020Q33987140-1538BE29-9113-420A-8115-DEAD2010A1D9Q34315276-421C4BAD-82C8-415D-9282-B8E9ACB38C89Q34341005-D6D66FB5-3A30-452D-BBDE-1D961976D327Q34764061-F1F6EEDF-335E-4BF8-A7A4-BDA41829DC01Q35802879-5B6785CB-F892-430E-B147-CA1885A84144Q35861077-14E10E93-95B3-4A38-A5F7-C9F53A703525Q36069707-80F0C2BD-54B3-4433-BEC6-57C81C18BD07Q36105739-C74E5C1B-47B7-4813-9900-5684001A19ADQ36422465-60EA40C4-E28C-42BB-9375-4B1713B406E7Q36707087-390410B4-252E-42D3-AB0D-8F60DE992819Q36895785-13731134-62D5-4BCC-A0C9-A16CCADC4D5AQ37240478-0B796DC4-F7DA-47DC-99B0-0F6B3E326A61Q37307216-4F86DEEE-2E8B-4B89-B5C5-2ED7D9AC4A8FQ37455625-D20B7BF2-6730-465D-9778-66D2EC86E4A8Q37589572-99248EC1-0176-4413-8BDE-3D546A74FD0CQ37657529-8E862933-3BBB-4827-BFBB-B1852EC72B35Q38115148-250916FE-288A-4132-B009-8626B23B8AD0Q38175976-D86063FB-2F4E-4BE2-96E7-9635988AC7DAQ38246459-6804B440-4EF5-4D9F-B292-BF6BB1CCF17FQ38412804-D989131A-1D4A-47BE-AB01-B1B043B2059BQ38745594-84520908-80CA-43BF-9664-2A4939D42EE5Q39330717-10F64725-1DC7-4B8B-9EA8-2A34FFC882B9Q39410461-4F8D5EB4-7EA3-46FA-811F-F0F02B0111BEQ40813682-904C96AA-DC31-443A-B231-6377BF902CE8Q41435645-A12F2295-F6DD-4B8C-B1E0-F94C6E8B7CE2Q42044259-CFB63E87-DD1F-4D52-BB34-D9F9AD338B98Q42488015-9A863B15-1496-4B01-915E-61F70A914091Q46088505-685C0CE8-6E5B-4A4F-9DEE-70D1F7B15DD6Q46262285-0D4E9402-BC36-43E1-B022-7CBDCD5A0554Q48590768-F0BAF930-8485-4989-BB81-20A5D1FF4737Q50495647-E041176D-D2F1-4689-A460-410005B87DE2Q52372774-83A04117-8E57-4C82-BE41-985F2ED0F1FCQ55183242-EE801783-C809-4267-8249-40A07DD6637D
P2860
Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.
@en
Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.
@nl
type
label
Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.
@en
Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.
@nl
prefLabel
Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.
@en
Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.
@nl
P2093
P2860
P1476
Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy
@en
P2093
Barry J Byrne
Bryan L Scott
Elizabeth A Martin
Evgeny I Tsimerinov
Francine Anene
Rita Barresi
Robert M Elashoff
Ronald G Victor
Swaminatha V Gurudevan
P2860
P304
P356
10.1126/SCITRANSLMED.3004327
P407
P577
2012-11-01T00:00:00Z